Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.

Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE.

Kidney Int. 1995 Jan;47(1):186-92.

2.

Outcome and risk factors for left ventricular disorders in chronic uraemia.

Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE.

Nephrol Dial Transplant. 1996 Jul;11(7):1277-85.

PMID:
8672023
3.

The prognostic importance of left ventricular geometry in uremic cardiomyopathy.

Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barré PE.

J Am Soc Nephrol. 1995 Jun;5(12):2024-31.

4.

Correlates of subclinical left ventricular dysfunction in ESRD.

Fathi R, Isbel N, Haluska B, Case C, Johnson DW, Marwick TH.

Am J Kidney Dis. 2003 May;41(5):1016-25.

PMID:
12722036
5.

Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients.

Yamada S, Ishii H, Takahashi H, Aoyama T, Morita Y, Kasuga H, Kimura K, Ito Y, Takahashi R, Toriyama T, Yasuda Y, Hayashi M, Kamiya H, Yuzawa Y, Maruyama S, Matsuo S, Matsubara T, Murohara T.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1793-8. doi: 10.2215/CJN.00050110. Epub 2010 Jul 1.

6.

Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease.

Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE.

J Am Soc Nephrol. 1996 May;7(5):728-36.

7.

Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.

deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, Christenson R, Uretsky B, Smiley M, Gold J, Muniz H, Badalamenti J, Herzog C, Henrich W.

JAMA. 2003 Jul 16;290(3):353-9.

PMID:
12865376
8.

Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease.

Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE.

J Am Soc Nephrol. 2000 May;11(5):912-6.

9.

Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation.

Patel RK, Jardine AG, Mark PB, Cunningham AF, Steedman T, Powell JR, McQuarrie EP, Stevens KK, Dargie HJ, Jardine AG.

Am J Kidney Dis. 2010 Jun;55(6):1088-96. doi: 10.1053/j.ajkd.2009.12.033. Epub 2010 Mar 25.

10.

Associations of Macro- and Microvascular Endothelial Dysfunction With Subclinical Ventricular Dysfunction in End-Stage Renal Disease.

Dubin RF, Guajardo I, Ayer A, Mills C, Donovan C, Beussink L, Scherzer R, Ganz P, Shah SJ.

Hypertension. 2016 Oct;68(4):913-20. doi: 10.1161/HYPERTENSIONAHA.116.07489. Epub 2016 Aug 22.

11.

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS.

Kidney Int. 1995 Mar;47(3):884-90.

12.

Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.

Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE.

Kidney Int. 1996 May;49(5):1379-85.

13.

Impact of left ventricular hypertrophy on survival in end-stage renal disease.

Silberberg JS, Barre PE, Prichard SS, Sniderman AD.

Kidney Int. 1989 Aug;36(2):286-90.

14.

Cardiac function and hematocrit level.

Harnett JD, Kent GM, Foley RN, Parfrey PS.

Am J Kidney Dis. 1995 Apr;25(4 Suppl 1):S3-7.

PMID:
7702071
15.

Heart rate as independent prognostic factor for mortality in normotensive hemodialysed patients.

Cice G, Di Benedetto A, D'Andrea A, D'Isa S, De Gregorio P, Marcelli D, Gatti E, CalabrĂ² R.

J Nephrol. 2008 Sep-Oct;21(5):704-12.

PMID:
18949725
16.

Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS.

J Am Soc Nephrol. 2004 Apr;15(4):1029-37.

17.

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease.

Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE.

Am J Kidney Dis. 1996 Jul;28(1):53-61.

PMID:
8712222
18.

Echocardiographic strain and mortality in Black Americans with end-stage renal disease on hemodialysis.

Pressman GS, Seetha Rammohan HR, Romero-Corral A, Fumo P, Figueredo VM, Gorcsan J 3rd.

Am J Cardiol. 2015 Nov 15;116(10):1601-4. doi: 10.1016/j.amjcard.2015.08.028. Epub 2015 Sep 3.

PMID:
26410606
19.

Left atrial volume predicts mortality in low-risk dialysis population on long-term low-salt diet.

Ozdogan O, Kayikcioglu M, Asci G, Ozkahya M, Toz H, Sezis M, Can LH, Ok E.

Am Heart J. 2010 Jun;159(6):1089-94. doi: 10.1016/j.ahj.2010.03.020.

PMID:
20569724
20.

Cardiac disease in dialysis patients in a Jamaican hospital: echocardiographic findings that predict mortality.

Chung A, Iheonunekwu N, Gilbert DT, Barton EN.

West Indian Med J. 2007 Jun;56(3):305-8.

PMID:
18072419

Supplemental Content

Support Center